Literature DB >> 26175856

MMP14 regulates cell migration and invasion through epithelial-mesenchymal transition in nasopharyngeal carcinoma.

Tinghua Yan1, Zhonghao Lin2, Jinhua Jiang3, Suiwan Lu1, Miaoan Chen2, Huaxing Que1, Xiangsheng He1, Ganbo Que1, Jianfeng Mao1, Jinan Xiao4, Qingwei Zheng4.   

Abstract

Matrix metalloproteinase 14 (MMP14) has been shown to play a significant role in several types of cancers, but little is known about the function of MMP14 in nasopharyngeal carcinoma (NPC) carcinogenesis. The aim of this study was to investigate the role of MMP14 in NPC using NPC tumor samples or tissue microarray. We have shown that MMP14 was increased in NPC samples compared with normal nasopharynx (NP) tissues in microarray data (GSE13597). Both MMP14 mRNA and protein expression were markedly higher in NPC tissues than in NP tissues. High levels of MMP14 protein were found positively correlate with the status of late clinical stages of tumor and tumor with lymph node metastasis. Moreover, we have shown that MMP14 expression promoted the cell migration and invasion of NPC cells in vitro and regulated the expression of EMT-associated genes. Our data demonstrated that MMP14 plays an important role in regulation of migration and invasion of NPC cells, and constitutes a potential novel therapeutic target for NPC.

Entities:  

Keywords:  Matrix metalloproteinase 14; biomarker; epithelial-mesenchymal transition; metastasis; nasopharyngeal carcinoma

Year:  2015        PMID: 26175856      PMCID: PMC4494146     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  29 in total

Review 1.  The emerging role of MMP14 in brain tumorigenesis and future therapeutics.

Authors:  Ilya Ulasov; Ruiyang Yi; Donna Guo; Purvaba Sarvaiya; Charles Cobbs
Journal:  Biochim Biophys Acta       Date:  2014-03-19

2.  Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.

Authors:  Keun-Woo Lee; Jeong Hoon Kim; Songying Han; Chang-Ohk Sung; In-Gu Do; Young-Hyeh Ko; Sung Hee Um; Seok-Hyung Kim
Journal:  Ann Surg Oncol       Date:  2011-07-06       Impact factor: 5.344

3.  Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?

Authors:  Christina Scheel; Robert A Weinberg
Journal:  Int J Cancer       Date:  2011-08-29       Impact factor: 7.396

4.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

Authors:  A Okada; J P Bellocq; N Rouyer; M P Chenard; M C Rio; P Chambon; P Basset
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration.

Authors:  Thirupandiyur S Udayakumar; Man Ling Chen; Elisabeth L Bair; Dorothea C Von Bredow; Anne E Cress; Raymond B Nagle; G Timothy Bowden
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

6.  A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth.

Authors:  Juho Suojanen; Tuula Salo; Erkki Koivunen; Timo Sorsa; Emma Pirilä
Journal:  Cancer Biol Ther       Date:  2009-12-19       Impact factor: 4.742

Review 7.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

8.  A matrix metalloproteinase expressed on the surface of invasive tumour cells.

Authors:  H Sato; T Takino; Y Okada; J Cao; A Shinagawa; E Yamamoto; M Seiki
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

9.  Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer.

Authors:  Chun-Wei Peng; Lin-Wei Wang; Min Fang; Gui-Fang Yang; Yan Li; Dai-Wen Pang
Journal:  J Transl Med       Date:  2013-06-20       Impact factor: 5.531

10.  Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression.

Authors:  Sonia Pahwa; Maciej J Stawikowski; Gregg B Fields
Journal:  Cancers (Basel)       Date:  2014-02-17       Impact factor: 6.639

View more
  19 in total

1.  Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.

Authors:  Valeria Arkadash; Gal Yosef; Jason Shirian; Itay Cohen; Yuval Horev; Moran Grossman; Irit Sagi; Evette S Radisky; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

2.  Inferring novel genes related to oral cancer with a network embedding method and one-class learning algorithms.

Authors:  Lei Chen; Yu-Hang Zhang; Guohua Huang; Xiaoyong Pan; Tao Huang; Yu-Dong Cai
Journal:  Gene Ther       Date:  2019-08-27       Impact factor: 5.250

3.  Integrative analysis of BSG expression in NPC through immunohistochemistry and public high-throughput gene expression data.

Authors:  Li Gao; Jin-Cai Zhong; Wen-Ting Huang; Yi-Wu Dang; Min Kang; Gang Chen
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

4.  Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy.

Authors:  Minzhu Ren; Zhenhua Wang; Guowei Gao; Xiaohua Gu; Liping Wu; Lijun Chen
Journal:  Tumour Biol       Date:  2016-04-05

5.  Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas.

Authors:  Maria V Bogachek; Jung M Park; James P De Andrade; Allison W Lorenzen; Mikhail V Kulak; Jeffrey R White; Vivian W Gu; Vincent T Wu; Ronald J Weigel
Journal:  Stem Cell Reports       Date:  2016-12-01       Impact factor: 7.765

6.  Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model.

Authors:  Gina Bouchard; Hélène Therriault; Sameh Geha; Rachel Bujold; Caroline Saucier; Benoit Paquette
Journal:  Br J Cancer       Date:  2017-01-19       Impact factor: 7.640

7.  Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)-A CleavEx Based Analysis.

Authors:  Katherine Falkowski; Ewa Bielecka; Ida B Thøgersen; Oliwia Bocheńska; Karolina Płaza; Magdalena Kalińska; Laura Sąsiadek; Małgorzata Magoch; Aleksandra Pęcak; Magdalena Wiśniewska; Natalia Gruba; Magdalena Wysocka; Anna Wojtysiak; Magdalena Brzezińska-Bodal; Kamila Sychowska; Anastasija Pejkovska; Maren Rehders; Georgina Butler; Christopher M Overall; Klaudia Brix; Grzegorz Dubin; Adam Lesner; Andrzej Kozik; Jan J Enghild; Jan Potempa; Tomasz Kantyka
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

8.  Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness.

Authors:  Gi-Cheon Kim; Ho-Keun Kwon; Choong-Gu Lee; Ravi Verma; Dipayan Rudra; Taemook Kim; Keunsoo Kang; Jong Hee Nam; Young Kim; Sin-Hyeog Im
Journal:  Oncogenesis       Date:  2018-11-23       Impact factor: 7.485

9.  A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells.

Authors:  Dana Koslawsky; Marianna Zaretsky; Ron Alcalay; Ohad Mazor; Amir Aharoni; Niv Papo
Journal:  Oncotarget       Date:  2018-06-19

10.  NOGO-B promotes EMT in lung fibrosis via MMP14 mediates free TGF-beta1 formation.

Authors:  Ye Xiong; Jing Zhang; Lingzhi Shi; Yunye Ning; Ying Zhu; Si Chen; Meng Yang; Jingyu Chen; Guo-Wu Zhou; Qiang Li
Journal:  Oncotarget       Date:  2017-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.